


Medi-Weightloss Chester operates as a physician-supervised weight management clinic in Chester, Virginia, focusing on evidence-based protocols that combine GLP-1 receptor agonist medications with structured nutritional guidance and metabolic monitoring. The clinic serves patients throughout the greater Richmond area who require medical intervention for obesity, metabolic syndrome, and type 2 diabetes management. Unlike self-directed weight loss programs, Medi-Weightloss Chester provides weekly accountability visits during active weight reduction phases, with providers adjusting medication dosing and nutritional plans based on individual metabolic response and laboratory markers.
Medi-Weightloss Chester's peptide therapy menu includes Liraglutide, Semaglutide, and Tirzepatide, with treatment protocols customized based on individual health goals and lab work. Additional peptide options may be available based on medical necessity and FDA guidelines.
Medi-Weightloss Chester extends its medical weight management services to adolescent patients aged 12 and older who meet clinical criteria for obesity intervention, following pediatric endocrinology guidelines that now support earlier pharmacological intervention in cases where lifestyle modification alone proves insufficient. The adolescent program requires parental involvement and includes family education components addressing nutrition, activity patterns, and behavioral factors contributing to weight gain. For corporate clients in the Chester and Richmond business community, the clinic offers workplace wellness consultations and group education sessions, recognizing that employer-sponsored weight management programs improve productivity metrics and reduce healthcare utilization costs associated with obesity-related comorbidities.
Patients initiating treatment at the Chester location complete comprehensive intake assessments including body composition analysis, metabolic panel testing, hemoglobin A1c measurement, and lipid profiling to establish baseline health status and identify contraindications to GLP-1 therapy. The clinic's protocol requires in-person visits rather than telehealth consultations, allowing providers to perform physical examinations, monitor blood pressure trends, and assess for medication side effects that may not be apparent through virtual encounters. Weekly visits during the initial 12-16 week phase provide structured accountability, with patients receiving meal planning guidance calibrated to their medication response and weight loss velocity. As patients approach goal weight, visit frequency transitions to biweekly and then monthly maintenance schedules.
With a perfect 5.0-star rating across 16 Google reviews, Medi-Weightloss Chester has established a reputation in the Chester community for accessible medical weight management that addresses the practical barriers many patients face when attempting to access GLP-1 medications through traditional endocrinology or primary care channels. The clinic's pharmacy partnership model resolves the prescription fulfillment delays and insurance obstacles that often derail weight loss attempts, while the structured visit schedule provides the medical supervision necessary for safe dose escalation and complication management. For Virginia residents seeking physician-guided weight reduction with pharmaceutical support, the Chester location offers a specialized alternative to general practice weight management or unsupervised online prescription services.
Medi-Weightloss Chester
Melissa Stephens, PA-C
Tarah Slate, FNP-C
Provider
Topics Mentioned in Reviews
Weight Loss Program
GLP-1 Medications
Diabetes Treatment
IV Therapy
Adolescent Program
Vitamin & Nutrient Injections
Compounded Semaglutide
Semaglutide - Available - First Month $99
Compounded Tirzepatide
Tirzepatide - Available - First Month $199
Saxenda
Liraglutide - Available
Zepbound
Tirzepatide - Available
Wegovy
Semaglutide - Available
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.